BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc., a privately-held biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that Derek Cole has been appointed vice president, investor relations and corporate communications, effective immediately.
